Washington State Chief Medical Officer Touts Cost Effectiveness
This article was originally published in The Gray Sheet
Executive Summary
As the debate over what role cost-effectiveness research should play in health reform continues on a national level, some states have already made cost comparisons a routine part of the policy making process
You may also be interested in...
U.K. Panel Says: Continue DES Use, But Limit Price Premium Over Bare Metal
The United Kingdom's National Institute of Health and Clinical Excellence has retreated from its August 2007 recommendation that the country's National Health Service stop paying for drug-eluting stents after being bombarded with criticism from interventional cardiologists and stent manufacturers
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.